Associate Professor and Chief, Facial Plastic and Reconstructive Surgery
Otolaryngology (ENT)
Dr. Jeffrey S. Moyer, MD
|
|
Give Review
Jeffrey Moyer practices Otolaryngology (ENT). He attended University of North Carolina at Chapel Hill School of Medicine. University of North Carolina at Chapel Hill School of Medicine is one of the top medical schools in the US. University of North Carolina at Chapel Hill School of Medicine has a rank of 22 in research and a 2 in primary care He over the years received 3 awards: "CMS Meaningful Use Stage 1 Certification", "Fellow (FAAO-HNS)" and "Fellow (FACS)". Jeffrey Moyer is a published physician as well. He has 42 publications published. The latest was: Hemiglossectomy tongue reconstruction: Modeling of elevation, protrusion, and functional outcome using receiver operator characteristic curve.
Publications
- Exploration for an Algorithm for Deintensification to Exclude the Retropharyngeal Site From Advanced Oropharyngeal Squamous Cell Carcinoma Treatment.
- HemigLossectomy tongue reconstruction: Modeling of elevation, protrusion, and functional outcome using receiver operator characteristic curve.
- Immunotherapy for Head and neck squamous cell carcinoma.
- Anticoagulant Complications in Facial Plastic and Reconstructive Surgery.
- Matted Nodes Predict Distant Metastasis in Advanced Stage III/IV Oropharyngeal Squamous Cell Carcinoma.
- Epigenetic alterations in metastatic cutaneous carcinoma.
- Circulating CD4-positive lymphocyte levels as predictor of response to induction chemotherapy in patients with advanced laryngeal Cancer.
- High-Risk Human Papillomavirus Detection in Oropharyngeal, Nasopharyngeal, and Oral Cavity Cancers: Comparison of Multiple Methods.
- Restoration of the orbital aesthetic subunit with the thoracodorsal artery system of flaps in patients undergoing radiation therapy.
- Patterns of nodal metastasis and prognosis in human papillomavirus positive oropharyngeal squamous cell carcinoma.
- Age-related histologic changes in human nasal cartilage.
- Biomarkers in advanced larynx Cancer: Triological society thesis.
- Weekly chemotherapy with radiation versus high-dose cisplatin with radiation as organ preservation for patients with HPV positive and HPV negative locally advanced squ...
- Upper blepharoplasty: the aesthetic ideal.
- Matted nodes: Poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status.
- Interpolated subcutaneous fat pedicle melolabial flap for large nasal lining defects.
- Methicillin-Resistant Staphylococcus aureus-Associated Infections following Septorhinoplasty.
- Diagnostic modalities for distant metastasis in Head and neck squamous cell carcinoma: are we changing life expectancy?
- Chemo-IMRT of Oropharyngeal Cancer Aiming to Reduce Dysphagia: Swallowing Organs Late Complication Probabilities and Dosimetric Correlates.
- Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell Cancer.
- Maxillomandibular-labial reconstruction: an autogenous transplant as an alternative to allogenic Face transplantation.
- Thoracodorsal artery scapular tip autogenous transplant: vascularized Bone with a long pedicle and flexible soft tissue.
- Chemotherapy alone for organ preservation in advanced laryngeal Cancer.
- Reconstruction of extensive nasal defects with staged bilateral paramedian foreHead flaps.
- Intensity-modulated chemoradiotherapy aiming to reduce Dysphagia in patients with oropharyngeal cancer: clinical and functional results.
- Predictors of satisfaction with Facial plastic surgery: results of a prospective study.
- HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.
- Tobacco use in human papillomavirus-positive advanced oropharynx Cancer patients related to increased risk of distant metastases and tumor recurrence.
- The pattern of failure after reirradiation of recurrent squamous cell head and neck Cancer: implications for defining the targets.
- Auricular tophi as the initial presentation of gout.
- Skin Cancer of the head and neck with perineural invasion: defining the clinical target volumes based on the pattern of failure.
- Microvascular reconstruction of the orbital complex.
- Early prediction of outcome in advanced head-and-neck Cancer based on tumor blood volume alterations during therapy: a prospective study.
- IntratumOral dendritic cells and chemoradiation for the treatment of murine squamous cell carcinoma.
- Lateral oromandibular defect: when is it appropriate to use a bridging reconstruction plate combined with a soft tissue revascularized flap?
- Early vaccination with tumor-lysate-pulsed dendritic cells after allogeneic Bone marrow transplantation has antitumor effects.
- Complications of rhytidectomy.
- Osseocutaneous radial forearm free tissue transfer for repair of complex midFacial defects.
- Contemporary Skull base reconstruction.
- Current thoughts on the role of chemotherapy and radiation in advanced head and neck Cancer.
- Generation of a novel dendritic-cell vaccine using melanoma and squamous Cancer stem cells.
Schools
University Of North Carolina Chapel Hill School Of Medicine
University Of Mi Hosps and Health Ctrs
Procedures Preformed
- Ablation or Excision of Nasal Turbinates
- Continuous Positive Airway Pressure (CPAP)
- Diagnostic Nasal and-or Sinus Endoscopy
- Ear Plastic Surgery (Otoplasty)
- View All
Conditions Treated
- Acoustic Neuroma
- Allergic Rhinitis
- Bell's Palsy
- Broken Nose
- View All
Doctors Specialties
- Ear, Nose, and Throat
- Otolaryngology (ENT)
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
- Fellow (FAAO-HNS)
- Fellow (FACS)
Education
-
University of Michigan Hospitals and Health Centers -
University of North Carolina at Chapel Hill School of Medicine
Hospital
-
University of Michigan Hospitals and Health Centers
Drug Facts
| NPI NUMBER | 1104914621 | |
| NPPES Provider LastName | MOYER | |
| NPPES Provider FirstName | JEFFREY | |
| NPPES Provider ZIPCode | 481095312 | |
| NPPES Provider State | MI | |
| Specialty Description | Otolaryngology | |
| Total Claim Count | 46.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 17.0 | |
| Percent Opioid Claims | 36.96 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104914621 |
| Last Name Of The Provider | MOYER |
| First Name Of The Provider | JEFFREY |
| View All |
Similar Doctors
|
|
Dr. Andrew J. Rosko, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Steven A. Telian, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Douglas B. Chepeha, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Norman D. Hogikyan, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Gregory J. Basura, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Katherine D. Heidenreich, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Matthew E. Spector, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jesse T. Ryan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Andrew C. Birkeland, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xue Zhao, MD |
|
|
Dr. Kyle K. Vankoevering, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David A. Zopf, MD
This Doctor is OpenDoctor Recommended.
|